Toxic Effects of Chemicals: Difficulties in Extrapolating Data from Animals to Man

References

• Garattini S. Short term tests for neurotoxicity. Meeting of Scientific Group of Methodologies for the Safety Evaluation of Chemicals (SGOMSEC 4) National Research Council, OttawaCanada, August 13–16, 1984, in press
   Google Scholar
• Animals and Alternatives in Toxicity Testing, M. Balls, R.J. Riddel, A.N. Worden. Academic Press, London 1983
   Google Scholar
• Boxenbaum H. Interspecies scaling allometry, physiological time, and the ground plan of pharmacokinetics. J. Pharmacokinet. Biopharm. 1982; 10: 201
   PubMedGoogle Scholar
• Boxenbaum H. Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin. J. Pharmacokinet. Biopharm. 1980; 8: 165
   PubMedGoogle Scholar
• Bonati M., Latini R., Tognoni G., Young J.F., Garattini S. Interspecies comparison of in vivo caffeine pharmacokinetics in man, monkey, rabbit, rat and mouse. Drug Metab. Rev. 1984; 15: 1355
   PubMed Web of Science ®Google Scholar
• Hill B.T., Whelan R.D.H., Rupniak H.T., Dennis L.Y., Rosholt M.A. A comparative assessment of the in vitro effects of drugs on cells by means of colony assays or flow microfluorimetry. Cancer Chemother. Pharmacol. 1981; 7: 21
   PubMedGoogle Scholar
• D'Incalci M., Erba E., Vaghi M., Morasca L. In vitro cytotoxicity of VP 16 on primary tumor and metastasis of Lewis lung carcinoma. Eur. J. Cancer Clin. Oncol. 1982; 18: 377
   PubMedGoogle Scholar
• Broggini M., Colombo T., D'Incalci M. Activity and pharmacokinetics of teniposide in Lewis lung carcinoma-bearing mice. Cancer Treat. Rep. 1983; 67: 555
   PubMedGoogle Scholar
• Ouslander J.G. Drug therapy in the elderly. Ann. Intern. Med. 1981; 95: 711
   PubMed Web of Science ®Google Scholar
• Latini R., Bonati M., Marzi E., Tacconi M.T., Sadurska B., Bizzi A. Caffeine disposition and effects in young and one year old rats. J. Pharm. Pharmacol. 1980; 32: 596
   PubMed Web of Science ®Google Scholar
• Yacobi A., Kamath B.L., Stampfli H.F., Look Z.M., Lai C-M. Age-related pharmacokinetics ofN-acetylprocainamide in rats. J. Pharm. Sci. 1983; 72: 789
   PubMedGoogle Scholar
• Chang K.C., Lauer B.A., Bell T.D., Chai H. Altered teophylline pharmacokinetics during acute respiratory viral illness. Lancet 1978; i: 1132
   Google Scholar
• Giampietri A., Puccetti P., Contessa A.R. Depression of hepatic biotransformation by chemical immunoadjuvants. J. Immunopharmacol. 1981; 3: 251
   PubMed Web of Science ®Google Scholar
• Kramer P., McClain C.J. Depression of aminopyrine metabolism by influenza vaccination. N. Engl. J. Med. 1981; 305: 1262
   PubMed Web of Science ®Google Scholar
• Donelli M.G., D'Incalci M., Garattini S. Pharmacokinetic studies of anticancer drugs in tumor bearing animals. Cancer Treat. Rep. 1984; 68: 381
   PubMedGoogle Scholar
• Axelrod J., Reichenthal J. The fate of caffeine in man and a method for its estimation in biological material. J. Pharmacol. Exp. Ther. 1953; 107: 519
   PubMed Web of Science ®Google Scholar
• Blanchard J. Protein binding of caffeine in young and elderly males. J. Pharm. Sci. 1982; 71: 1415
   PubMed Web of Science ®Google Scholar
• Piazza E., Broggini M., Trabattoni A., Natale N., Libretti A., Donelli M.G. Adriamycin distribution in plasma and blood cells of cancer patients with altered hematocrit. Eur. J. Cancer Clin. Oncol. 1981; 17: 1089
   PubMedGoogle Scholar
• Broggini M., Colombo T., Garattini S., Donelli M.G. Influence of tumor on adriamycin concentration in blood cells. Cancer Chemother. Pharmacol. 1980; 4: 209
   PubMedGoogle Scholar
• Manara L., Coccia P., Croci T. Persistent tissue levels of TCDD in the mouse and their reduction as related to prevention of toxicity. Drug Metab. Rev. 1982; 13: 423
   PubMed Web of Science ®Google Scholar
• McNulty W.P., Nielsen-Smith K.A., Lay J. O., Jr., Lippstreu D.L., Kangas N.L., Lyon P.A., Gross M.L. Persistence of TCDD in monkey adipose tissue. Food Chem. Toxicol. 1982; 20: 985
   PubMedGoogle Scholar
• Luft F.C., Kleit S.A. Renal parenchymal accumulation of aminoglycoside antibiotics in rats. J. Infect. Dis. 1974; 130: 656
   PubMed Web of Science ®Google Scholar
• Broggini M., Colombo T., Martini A., Donelli M.G. Studies on the comparative distribution and biliary excretion of doxorubicin and 4′epi-doxorubicin in mice and rats. Cancer Treat. Rep. 1980; 64: 897
   PubMedGoogle Scholar
• Bizzi A., Ceriani L., Gerundino M., Spina A., Tacconi M.T., Veneroni E. Adriamycin causes hyperlipemia as a consequence of nephrotoxicity. Toxicol. Lett. 1983; 18: 291
   PubMed Web of Science ®Google Scholar
• Bertani T., Remuzzi G., Rocchi G., Delaini F., Sacchi G., Donati M.B. Steroids and adriamycin nephrosis. Appl. Pathol. 1984; 2: 33
   Google Scholar
• Weiss R.B., Poster D.S. The renal toxicity of cancer chemotherapeutic agents. Cancer Treat. Rev. 1982; 9: 37
   PubMedGoogle Scholar
• Fajardo L.F., Eltringham J.R., Stewart J.R., Klauber M.R. Adriamycin nephrotoxicity. Lab. Invest. 1980; 43: 242
   PubMed Web of Science ®Google Scholar
• Blasberg R., Lajtha A. Heterogeneity of the mediated transport systems of amino acid uptake in brain. Brain Res. 1966; 1: 86
   PubMedGoogle Scholar
• Blasberg R.G. Specificity of cerebral amino acid transport: a kinetic analysis. Progr. Brain Res. 1968; 29: 245
   PubMedGoogle Scholar
• Bonati M., Kanto J., Tognoni G. Clinical pharmacokinetics of cerebrospinal fluid. Clin. Pharmacokinet. 1982; 7: 312
   PubMed Web of Science ®Google Scholar
• Saunders N.R. Ontogeny of the blood-brain barrier. Exp. Eye Res. 1977; 25: 523, Suppl.
   PubMedGoogle Scholar
• Mollgøard K., Saunders N.R. Complex tight junctions of epithelial and of endothelial cells in early foetal brain. J. Neurocytol. 1975; 4: 453
   PubMedGoogle Scholar
• Olsson Y., Klatzo I., Sourander P. Blood-brain barrier to albumin in embryonic new born and adult rats. Acta Neuropathol. 1968; 10: 117
   PubMedGoogle Scholar
• Perez V.J., Olney J.W. Accumulation of glutamic acid in the arcuate nucleus of the hypothalamus of the infant mouse following subcutaneous administration of monosodium glutamate. J. Neurochem. 1972; 19: 1777
   PubMedGoogle Scholar
• Perez V.J., Olney J.W., Robin S.J. Glutamate accumulation in infant mouse hypothalamus: influence of temperature. Brain Res. 1973; 59: 181
   PubMedGoogle Scholar
• Airoldi L., Bonfanti M., Ghezzi P., Salmona M., Garattini S. Effect of oral monosodium glutamate on glutamic acid levels in the nucleus arcuatus of the hypothalamus and on serum osmolality of adult and infant mice. Toxicol. Lett. 1980; 7: 107
   PubMedGoogle Scholar
• Olney J.W. Excitotoxic amino acids: research applications and safety implications. Glutamic Acid: Advances in Biochemistry and Physiology, L. J. Filer, Jr, S. Garattini, M.R. Kare, W.A. Reynolds, R.J. Wurtman. Raven Press, New York 1979; 287
   Google Scholar
• Garattini S. Evaluation of the neurotoxic effects of glutamic acid. Nutrition and the Brain, R.J. Wurtman, J.J. Wurtman. Raven Press, New York 1979; Vol. 4: 79
   Google Scholar
• Reynolds W.A., Lemkey-Johnston N., Stegink L.D. Morphology of the fetal monkey hypothalamus after in utero exposure to monosodium glutamate. Glutamic Acid: Advances in Biochemistry and Physiology. Raven Press, New York 1979; 217
   Google Scholar
• Boyd M.R. Evidence for the Clara cell as a site of cytochrome P450-dependent mixed-function oxidase activity in lung. Nature (London) 1977; 269: 713
   PubMed Web of Science ®Google Scholar
• Colombo T., Broggini M., Garattini S., Donelli M.G. Differential adriamycing distribution to blood components. Eur. J. Drug Metab. Pharmacokinet. 1981; 6: 115
   PubMedGoogle Scholar
• Nöel G., Peterson C., Trouet A., Tulkens P. Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblasts. Eur. J. Cancer 1978; 14: 363
   PubMed Web of Science ®Google Scholar
• Blanchard J.C., Schneider Y-J., Baurain R., Trouet A. Accumulation, metabolism and subcellular localization of daunorubicin, doxorubicin and their DNA-complexes in rat heart ventricles. Eur. J. Cancer 1981; 17: 297
   Google Scholar
• Broggini M., Ghersa P., Donelli M.G. Subcellular distribution of adriamycin in the liver and tumor of 3LL-bearing mice. Eur. J. Cancer Clin. Oncol. 1983; 19: 419
   PubMedGoogle Scholar
• Manara L., Mennini T., Cerletti C. 3H-reserpine persistently bound “in vivo” to rat brain subcellular components: limited removal by peanut oil extraction. Life Sci. 1974; 14: 2267
   PubMedGoogle Scholar
• Morselli P.L., Cassano G.B., Placidi G.F., Muscettola G.B., Rizzo M. Kinetics of the distribution of14C-diazepam and its metabolites in various areas of cat brain. The Benzodiazepines, S. Garattini, E. Mussini, L.O. Randall. Raven Press, New York 1973; 129
   Google Scholar
• Mennini T., Garattini S. Benzodiazepines receptor binding in vivα pharmacokinetic and pharmacological significance. Benzodiazepine Recognition Site Ligands: Biochemistry and Pharmacology, G. Biggio, E. Costa. Raven Press, New York 1983; 189
   Google Scholar
• Bandera R., Bollini P., Garattini S. Long-acting and short-acting benzodiazepines in the elderly: kinetic differences and clinical relevance. Curr. Med. Res. Opin. 1984; 8(4)94
   PubMedGoogle Scholar
• Caccia S., Dagnino G., Garattini S., Guiso G., Madonna R., Zanini M.G. Kinetics of fenfluramine isomers in the rat. Eur. J. Drug Metab. Pharmacokinet. 1981; 6: 297
   PubMedGoogle Scholar
• Bruce R.B., Maynard W. R., Jr. Fenfluramine metabolism. J. Pharm. Sci. 1968; 57: 1173
   PubMed Web of Science ®Google Scholar
• Caccia S., Ballabio M., Guiso G., Rocchetti M., Garattini S. Species differences in the kinetics and metabolism of fenfluramine isomers. Arch. Int. Pharmacodyn. 1982; 258: 15
   PubMedGoogle Scholar
• Latini R., Bonati M., Castelli D., Garattini S. Dose-dependent kinetics of caffeine in rats. Toxicol. Lett. 1978; 2: 267
   Web of Science ®Google Scholar
• Bonati M., Latini R., Sadurska B., Riva E., Galletti F., Borzelleca J.F., Tarka S.M., Arnaud M.J., Garattini S. I. Kinetics and metabolism of theobromine in male rats. Toxicology 1984; 30: 327
   PubMed Web of Science ®Google Scholar
• Colombo T., Broggini M., Torti L., Erba E., D'Incalci M. Pharmacokinetics of VP16-213 in Lewis lung carcinoma bearing mice. Cancer Chemother. Pharmacol. 1982; 7: 127
   PubMed Web of Science ®Google Scholar
• Garattini S., Bonati M. Acute toxicity of caffeine in mouse. Proc. 5th Int. Caffeine Workshop, Cancun, Mexico, June 17–21, 1984
   Google Scholar
• Olney J.W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969; 164: 719
   PubMed Web of Science ®Google Scholar
• Takasaki Y., Matzuzawa Y., Iwata S., O'hara Y., Yonetani S., Ichimura M. Toxicological studies of monosodium L-glutamate in rodents: relationship between routes of administration and neurotoxicity. Glutamic Acid: Advances in Biochemistry and Physiology, L. J. Filer, Jr., S. Garattini, M.R. Kare, W.A. Reynolds, R.J. Wurtman. Raven Press, New York 1979; 255
   Google Scholar
• Airoldi L., Bizzi A., Salmona M., Garattini S. Attempts to establish the safety margin for neurotoxicity of monosodium glutamate. Glutamic Acid: Advances in Biochemistry and Physiology, L. J. Filer, Jr., S. Garattini, M.R. Kare, W.A. Reynolds, R.J. Wurtman. Raven Press, New York 1979; 321
   Google Scholar
• Takasaki Y. Studies on brain lesions after administration of monosodium l-glutamate to mice. II. Absence of brain damage following administration of monosodium L-glutamate in the diet. Toxicology 1978; 9: 307
   PubMed Web of Science ®Google Scholar
• Arnold D.L., Moodie C.A., Grice H.C., Charbonneau S.M., Stavric B., Munro I.C. Long term toxicity of orthotoluenesulfonamide and saccharin in the rat. Toxicology Forum. The Eppley Institute for Research in Cancer, Omaha 1977
   Google Scholar
• Pantarotto C., Salmona M., Garattini S. Plasma kinetics and urinary elimination of saccharin in man. Toxicol. Lett. 1981; 9: 367
   PubMedGoogle Scholar
• Garattini S., Marcucci F., Mussini E. Biotransformation of drugs to pharmacologically active metabolites. Handbook of Experimental Pharmacology, Vol. 28, Concepts in Biochemical Pharmacology, Part 3, J.R. Gillette, J.R. Mitchell. Springer-Verlag, Berlin 1975; 113
   Google Scholar
• Garattini S. Importance of establishing the presence of drug active metabolites. Eur. J. Drug Metab. Pharmacokinet. 1983; 8: 97
   Google Scholar
• Parke D.V. Significance of the metabolism of xenobiotics for toxicological evaluation. Animals in Toxicological Research, I. Bartosek, A. Guaitani, E. Pacei. Raven Press, New York 1972; 127
   Google Scholar
• Microsomes and drug oxidations. Proc. 2nd Int. Symp., R.W. Estabrook, J.R. Gillette, K.C. Leibman. The Williams & Wilkins, Baltimore, Md. 1973
   Google Scholar
• Concepts in Biochemical Pharmacology. Handbook of Experimental Pharmacology, B.B. Brodie, J.R. Gillette. Springer-Verlag, Berlin 1971; Vol. 28: 1–3
   Google Scholar
• Ballabio M., Caccia S., Garattini S., Guiso G., Zanini M.G. Antileptazol activity and kinetics of clobazam and n-desmethyl-clobazam in the guinea-pig. Arch. Int. Pharmacodyn. 1981; 253: 192
   PubMedGoogle Scholar
• Caccia S., Guiso G., Garattini S. Brain concentration of clobazam andN-desmethylclobazam and antileptazol. J. Pharm. Pharmacol. 1980; 32: 295
   PubMedGoogle Scholar
• Garattini S., Mussini E., Marcucci F., Guaitani A. Metabolic studies on benzodiazepines in various animal species. The Benzodiazepines, S. Garattini, E. Mussini, I.O. Randall. Raven Press, New York 1973; 75
   Google Scholar
• Bellantuono C., Reggi V., Tognoni G., Garattini S. Benzodiazepines: clinical pharmacology and therapeutic use. Drugs 1980; 19: 195
   PubMed Web of Science ®Google Scholar
• Barbieri B., Abbruzzi R., Benigni A., Rizzardini M., Donelli M.G., Garattini S., Salmona M. Quantitative thin-layer chromatographic measurement ofN-trifluoroacetyladriamycin-14-valerate (AD32) and trifluoroacetyladriamycin (AD41) in plasma and tissues. J. Chromatogr. 1979; 163: 195
   PubMedGoogle Scholar
• Belvedere G., Tursi F., Jiritano L., Galletti F., Bonati M. Regioselectivity of caffeine metabolism in vivo and peripheral blood lymphocytes in different species. Cytochrome P-450, Biochemistry, Biophysics and Environment, E. Hietanen, M. Laitinen, O. Hänninen. Elsevier, Amsterdam 1982; 689
   Google Scholar
• Garattini S. Notes on xenobiotics metabolism. Ann. N.Y. Acad. Sci. 1983; 407: 1
   PubMedGoogle Scholar
• Martini A., Donelli M.G., Erba E., Morasca L., Dolfini E. Cytotoxic activity of in vitro activated cyclophosphamide on tumors in primary culture. Tumori 1976; 62: 185
   PubMedGoogle Scholar
• Connors T.A., Cox P.J., Farmer P.B., Foster A.B., Jarman M. Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide. Biochem. Pharmacol. 1974; 23: 115
   PubMed Web of Science ®Google Scholar
• Mennini T., Cotecchia S., Caccia S., Garattini S. Benzodiazepines: relationship between pharmacological activity in the rat and in vivo receptor binding. Pharmacol. Biochem. Behav. 1982; 16: 529
   PubMedGoogle Scholar
• Caccia S., Ballabio M., Garattini S. Relationship between camazepam,N-methyl-oxazepam and oxazepam brain concentrations and antileptazol effect in the rat. J. Pharm. Pharmacol. 1981; 33: 185
   PubMed Web of Science ®Google Scholar
• Ballabio M., Caccia S., Garattini S., Guiso G., Reginato R. Metabolic and pharmacological studies with N-methyl-N′-methyl-2′-allyl-2-benzoyl-4-chloroglycinanilide (F 1797). Arzneim. Forsch. 1983; 33: 959
   PubMedGoogle Scholar
• Volz M., Christ O., Kellner H.-M., Kuch H., Fehlhaber H.-W., Gantz D., Hajdu P., Cavagna F. Kinetics and metabolism of clobazam in animals and man. Br. J. Clin. Pharmacol. 1979; 7: 41S
   PubMed Web of Science ®Google Scholar
• Caccia S., Fong M.H., Garattini S., Notarnicola A. 1-Aryl-piperazine as active metabolites of drugs with an aryl-piperazine side-chain. Biochem. Pharmacol. 1985; 34: 393
   Web of Science ®Google Scholar
• Caccia S., Garattini S., Mancinelli A., Muglia M. Identification and quantitation of 1-(2-pyrimidinyl)piperazine, and active metabolite of the anxiolytic agent, buspirone, in rat plasma and brain. J. Chromatogr. 1982; 252: 310
   PubMed Web of Science ®Google Scholar
• Garattini S., Caccia S., Mennini T. Notes on buspirone's mechanisms of action. J. Clin. Psychiat. 1982; 43: 19
   PubMedGoogle Scholar
• Garattini S. Central mechanisms of fenfluramine and related anorectic drugs. Jap. J. Pharmacol. 1981; 31(Suppl.)29P
   Google Scholar
• Borsini F., Bendotti C., Aleotti A., Samanin R., Garattini S. d-Fenfluramine and d-norfenfluramine reduce food intake by acting on different serotonin mechanisms in the rat brain. Pharmacol. Res. Commun. 1982; 14: 671
   PubMedGoogle Scholar
• Garattini S. Central mechanisms of anorectic drugs. Recent Advances in Obesity Research: IV, J. Hirsch, T. VanItallie. J. Libbey & Co., London, in press
   Google Scholar
• Mennini T., Caccia S., Garattini S. Anorectic effect of fenfluramine isomers and metabolites: relationship between brain levels andin vitro potencies on serotonergic mechanisms. Psychopharmacology 1985; 85: 111
   PubMed Web of Science ®Google Scholar
• Samanin R., Mennini T., Ferraris A., Bendotti C., Borsini F., Garattini S. m-Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 1979; 308: 159
   Google Scholar
• Caccia S., Ballabio M., Samanin R., Zanini M.G., Garattini S. (-)-m-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodone. J. Pharm. Pharmacol. 1981; 33: 477
   PubMed Web of Science ®Google Scholar
• Caccia S., Ballabio M., Fanelli R., Guiso G., Zanini M.G. Determination of plasma and brain concentrations of trazodone and its metabolite, 1-m-chlorophenylpiperazine by gas-liquid chromatography. J. Chromatogr. 1981; 210: 311
   PubMed Web of Science ®Google Scholar
• Koe B.K. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J. Pharmacol. Exp. Ther. 1976; 199: 649
   PubMed Web of Science ®Google Scholar
• Catto B.A., Valencia C.I., Hafez K., Fairchild E.H., Webster L. T., Jr. 4-Keto niridazole: a major niridazole metabolite with central nervous system toxicity different than niridazole. J. Pharmacol. Exp. Ther. 1984; 228: 662
   PubMed Web of Science ®Google Scholar
• Mahmoud A.A. Schistosomiasis. N. Engl. J. Med. 1977; 297: 1329
   PubMed Web of Science ®Google Scholar
• Coutinho A., Barreto F.T. Treatment of hepatosplenic schistosomiasis mansoni with niridazole: relationships among liver function, effective dose, and side effects. Ann. N. Y. Acad. Sci. 1969; 160: 612
   PubMed Web of Science ®Google Scholar
• Faigle J.W., Coutinho A.D., Keberle H. The metabolism of niridazole (AMBILHARR) in man. II. Investigations on patients suffering from clinically advanced forms of schistosoma mansoni infection. Ann. Trop. Med. Parasitol. 1970; 64: 383
   PubMed Web of Science ®Google Scholar
• Blumer J.L., Simpson J.M., Lucas S.V., Webster L. T., Jr. Toxicogenetics of niridazole in inbred mice. J. Pharmacol. Exp. Ther. 1980; 212: 509
   PubMed Web of Science ®Google Scholar
• U'Prichard D.C., Snyder S.H. Distinct α-noradrenergic receptors differentiated by binding and physiological relationships. Life Sci. 1979; 24: 79
   PubMed Web of Science ®Google Scholar
• Maj J., Palider W., Rawlow A. Trazodone, a central serotonin antagonist and agonist. J. Neural Transm. 1979; 44: 237
   PubMedGoogle Scholar
• De Castellarnau C., Cerletti C., Dejana E., Galletti F., Latini R., Livio M., de Gaetano G. Salicylate-aspirin interaction and thrombosis prevention trials. Thromb. Haemost. 1981; 45: 294
   PubMedGoogle Scholar
• Dejana E., Cerletti C., De Castellarnau C., Livio M., Galletti F., Latini R., de Gaetano G. Salicylate aspirin in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition. J. Clin. Invest. 1981; 68: 1108
   PubMed Web of Science ®Google Scholar
• Cerletti C., Bonati M., Del Maschio A., Galletti F., Dejana E., Tognoni G., de Gaetano G. Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet function. J. Lab. Clin. Med. 1984; 103: 869
   PubMed Web of Science ®Google Scholar
• Dejana E., Costantini V., De Amicis G., Cerletti C., Lorenzi G., de Gaetano G. Differential salicylate-aspirin interaction on vascular prostacyclin and platelet thromboxane synthesis in patients undergoing saphenectomy. Proc. Soc. Exp. Biol. Med., in press
   Google Scholar
• Ravindranath V., Burka L.T., Boyd M.R. Reactive metabolites from the bioactivation of toxic methylfurans. Science 1984; 224: 884
   PubMed Web of Science ®Google Scholar
• Pantarotto C., Baggott J., Guaitani A., Donelli M.G., Garattini E. Secondary metabolism and covalent binding to cellular macromolecules. Quo Vadis? Short-Term Tests for Carcinogenesis, S. Garattini, G. Mazue, R. Roncucci, G.M. Williams. Elsevier, Amsterdam 1983; 166
   Google Scholar
• Pantarotto C., Fanelli R., Bidoli F., Morazzoni P., Salmona M., Szczawinska K. Arene oxides in styrene metabolism, new perspective in styrene toxicity. Scand. J. Work Environ. Health 1978; 4(2)67
   PubMedGoogle Scholar
• Donelli M.G., Guaitani A., Torti L., Damia G., Corti F., Bianchi M., Tortoreto M., Pantarotto C., Bartosek I. Different sensitivity of the two Walker 256 carcinoma lines to cyclophosphamide: correlation with drug distribution, biotransformation and macromolecule-binding. Cancer Treat, Rep., in press
   Google Scholar
• Garattini E., Colombo T., Donelli M.G., Catalani P., Bianchi M., D'Incalci M., Pantarotto C. Distribution, metabolism, and irreversible binding of hexamethylmelamine in mice bearing ovarian carcinoma. Cancer Chemother. Pharmacol. 1983; 11: 51
   PubMed Web of Science ®Google Scholar
• Garattini E., Villa P., Corti F., Romano M., Coccia P., Salmona M. Benzo(a)pyrene derived DNA covalent binding in rabbit hepatocyte is age-related. Toxicol. Lett., in press
   Google Scholar
• Ghezzi P., Donelli M.G., Pantarotto C., Facchinetti T., Garattini S. Evidence for covalent binding of adriamycin to rat liver microsomal proteins. Biochem. Pharmacol. 1981; 30: 175
   PubMed Web of Science ®Google Scholar
• Sinha B.K., Gregory J.L. Role of one-electron and two-electron reduction products of adriamycin and daunomycin in deoxyribonucleic acid binding. Biochem. Pharmacol. 1981; 30: 2626
   PubMed Web of Science ®Google Scholar
• Garattini E., Donelli M.G., Catalani P., Pantarotto C. Intact rat liver nuclei catalyze adriamycin irreversible interactions with DNA and nuclear proteins. Toxicol. Lett. 1983; 17: 343
   PubMed Web of Science ®Google Scholar
• Sinha B.K., Sik R.H. Binding of [14C]-adriamycin to cellular macromolecules in vivo. Biochem. Pharmacol. 1980; 29: 1867
   PubMed Web of Science ®Google Scholar
• Lown J.W., Sim S.-K., Majumdar K.C., Chang R.-Y. Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents. Biochem. Biophys. Res. Commun. 1977; 76: 705
   PubMed Web of Science ®Google Scholar
• Bachur N.R., Gordon S.L., Gee M.V. A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res. 1978; 38: 1745
   PubMed Web of Science ®Google Scholar
• Tritton T.R., Yee G. The anticancer agent adriamycin can be actively cytotoxic without entering cells. Science 1982; 217: 248
   PubMed Web of Science ®Google Scholar
• Luini W., Mantovani A., Garattini S. Effects of saccharin on primary humoral antibody production in rats. Toxicol. Lett. 1981; 8: 1
   PubMedGoogle Scholar
• Mantovani A., Luini W., Candiani G.P., Salmona M., Spreafico F., Garattini S. In vitro effects of saccharin on cell-mediated host defence mechanisms. Toxicol. Lett. 1980; 5: 287
   PubMed Web of Science ®Google Scholar
• Jori A., Caccia S. Further studies on brain concentrations of amphetamine and its metabolites in strains of mice showing different sensitivity to pharmacological effects of amphetamine. J. Pharm. Pharmacol. 1975; 27: 886
   PubMedGoogle Scholar
• Jori A., Rutczynski M. A genetic analysis of the hyperthermic response to d-amphetamine in two inbred strains of mouse. Psychopharmacology 1978; 59: 199
   PubMedGoogle Scholar
• Jori A., Garattini S. Catecholamine metabolism and amphetamine effects on sensitive and insensitive mice. Frontiers in Catecholamine Research, E. Usdin, S. Snyder. Pergamon Press, New York 1973; 939
   Google Scholar
• Garattini S. Some examples of resistance to psychotropic drugs in animals and man. Neuro-Psychopharmacology, P. Deniker, C. Radouco-Thomas, A. Villeneuve. Pergamon Press, Oxford 1978; 311
   Google Scholar
• Dolfini E., Kobayashi M. Studies with amphetamine in hyper and hypothyroid rats. Eur. J. Pharmacol. 1967; 2: 65
   PubMedGoogle Scholar
• Poland A., Glover E. Genetic expression of aryl hydrocarbon hydroxylase by 2,3,7,8-tetrach-lorodibenzo-p-dioxin: evidence for a receptor mutation in genetically non-responsive mice. Mol. Pharmacol. 1975; 11: 389
   Web of Science ®Google Scholar
• Greenlee W.F., Poland A. Nuclear uptake of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice. J. Biol. Chem. 1979; 254: 9814
   PubMed Web of Science ®Google Scholar
• Garattini S., Vecchi A., Sironi M., Mantovani A. Immunosuppressant activity of TCDD in mice. Chlorinated Dioxin & Related Compounds. Impact on the Environment, O. Hutzinger, R.W. Frei, E. Merian, F. Pocchiari. Pergamon Press, Oxford 1982; 403
   Google Scholar
• Vecchi A., Sironi M., Canegrati M.A., Garattini S. Comparison of immunosuppressive effects in mice of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzofuran. Chlorinated Dioxins and Dibenzofurans in the Total Environment, G. Choudhary, L.H. Keith, C. Rappe. Butterworth, Boston 1983; 397
   Google Scholar
• Okey A.B., Bondy G.P., Mason M.E., Kahl G.F., Eisen H.J., Guenthner T.M., Nebert D.W. Regulatory gene product of the Ah locus. Characterization of the cytosolic inducer-receptor complex and evidence for its nuclear translocation. J. Biol. Chem. 1979; 254: 11636
   PubMed Web of Science ®Google Scholar
• Morasca L., Balconi G., Erba E., D'Incalci M., Ottolenghi L., Salmona A., Garattini S. Pharmacokinetic approach to in vitro testing of ovarian cancer cell sensitivity. Oncology 1980; 37: 169
   PubMedGoogle Scholar
• Morasca L., Erba E., Vaghi M., Amato G., Pepe S., Mangioni C., Colombo N., Landoni F., D'Incalci M. In vitro cytotoxicity of VP16 on human ovarian cancer. J. Exp. Clin. Cancer Res. 1984; 3: 305
   Google Scholar
• Lu A.Y.H. Multiplicity of liver drug enzymes. Drug Metab. Rev. 1979; 10: 187
   PubMed Web of Science ®Google Scholar
• Oser L. Man is not a big rat. Toxicol. Forum. Feb. 16, 1981
   Google Scholar
• Mantovani A., Sessa C., Peri G., Allavena P., Introna M., Polentarutti N., Mangioni C. Intraperitoneal administration of Corynebacterium parvum in patients with ascitic ovarian tumors resistant to chemotherapy: effects on cytotoxicity of tumor-associated macrophages and NK cells. Int. J. Cancer 1981; 27: 437
   PubMed Web of Science ®Google Scholar
• Colotta F., Peri G., Villa A., Mantovani A. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. J. Immunol. 1984; 132: 936
   PubMed Web of Science ®Google Scholar
• Meltzer M.S. Tumoricidal responses in vitro of peritoneal macrophages from conventionally housed and germ-free nude mice. Cell Immunol. 1976; 22: 176
   PubMed Web of Science ®Google Scholar
• Mantovani A., Jerrells T.R., Dean J.H., Herberman R.B. Cytolytic and cytostatic activity on tumor cells of circulating human monocytes. Int. J. Cancer 1979; 23: 18
   PubMedGoogle Scholar
• Peri G., Biondi A., Bottazzi B., Polentarutti N., Bordignon C., Mantovani A. Tumoricidal and immunoregulatory activity of macrophages from human ovarian carcinomas. Adv. Exp. Med. Biol. 1982; 155: 737
   PubMedGoogle Scholar
• Boraschi D., Ghezzi P., Salmona M., Tagliabue A. IFN-β-induced reduction of superoxide amion generation by macrophages. Immunology 1982; 45: 621
   PubMed Web of Science ®Google Scholar
• Williams G.M. Genotoxic and epigenetic carcinogens: their identification and significance. Ann. N. Y. Acad. Sci. 1983; 407: 328
   PubMedGoogle Scholar
• Broggini M., Italia C., Colombo T., Marmonti L., Donelli M.G. Activity and distribution of Iv and oral 4-demethoxydaunorubicin in murine experimental tumors. Cancer Treat. Rep. 1984; 68: 739
   PubMedGoogle Scholar
• Broggini M., Colombo T., D'Incalci M., Donelli M.G., Gescher A., Garattini S. Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice. Cancer Treat. Rep. 1981; 65: 669
   PubMedGoogle Scholar
• Tung T.-C., Tung K.-S. Serum free amino acid levels after oral glutamate intake in infant and adult humans. Nutr. Rep. Int. 1980; 22: 431
   Google Scholar
• Bonati M., Latini R., Tognoni G., Young J.F., Garattini S. Interspecies comparison ofin vivo caffeine pharmacokinetics in man monkey, rabbit, rat and mouse. Drug Metab. Rev. 1984; 15: 1355
   PubMed Web of Science ®Google Scholar
• Abbruzzi R., Rizzardini M., Benigni A., Barbieri B., Donelli M.G., Salmona M. Possible relevance of N-trifluoroacetyladriamycin (AD 41) in the antitumoral activity of N-trifluoroacetyladriamycin-14-valerate (AD 32) in tumor bearing mice. I. Pharmacokinetic evidence. Cancer Treat. Rep. 1980; 64: 873
   PubMedGoogle Scholar
• Dejana E., Barbieri B., Cerletti C., Livio M., de Gaetano G. Impaired thromboxane production by newly formed platelets after aspirin administration to thrombocytopenic rats. Br. J. Haematol. 1980; 46: 465
   PubMed Web of Science ®Google Scholar
• Cortellaro M., Boschetti C., Antoniazzi V., Polli E.E., de Gaetano G., De Blasi A., Gerna M., Pezzi L., Garattini S. A pharmacokinetic and platelet function study of the combined administration of metoprolol and sulfinpyrazone to healthy volunteers. Thromb. Res. 1984; 34: 65
   PubMedGoogle Scholar
• Schieppati A., Dodesini P., Benigni A., Massazza M., Mecca G., Remuzzi G., Livio M., de Gaetano G., Rossi E.C. The metabolism of arachidonic acid by platelets in nephrotic syndrome. Kidney Int. 1984; 25: 671
   PubMedGoogle Scholar
• Roncaglioni M.C., de Gaetano G., Donati M.B. Some aspects of hematological toxicity in animals. Animals in Toxicological Research, I. Bartosek, A. Guaitani, E. Pacei. Raven Press, New York 1982; 77
   Google Scholar
• Di Minno G., Silver M.J., de Gaetano G. Prostaglandins as inhibitors of human platelet aggregation. Br. J. Haematol. 1979; 43: 637
   PubMedGoogle Scholar
• Lauri D., Cerletti C., de Gaetano G. Amplification of primary response of human platelets to platelet activating factor: Aspirin - sensitive and insensitive pathways. J. Lab. Clin. Med., in press
   Google Scholar
• de Gaetano G., Donati M.B., Reyers-Degli Innocenti I., Roncaglioni C. Defective ristocetin and bovine factor VIII-induced platelet aggregation in normal rats. Experientia 1975; 31: 500
   PubMedGoogle Scholar
• Lampugnani M.G., de Gaetano G. Effects of metabolized and unmetabolized arachidonate on rat platelet shape change. Am. J. Physiol. 1984; 247: H 440
   Google Scholar
• di Minno G., Bertelé V., Bianchi L., Barbieri B., Cerletti C., Dejana E., de Gaetano G., Silver M.J. Effects of an epoxymethano stable analogue of prostaglandin endoperoxides (U-46619) on human platelets. Thromb. Haemost. 1981; 45: 103
   PubMedGoogle Scholar
• De Clerck F., David J.-L., Janssen P.A.J. Inhibition of 5-hydroxy-tryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist. Agents and Actions 1982; 12: 388
   PubMedGoogle Scholar
• Lampugnani M.G., de Gaetano G. Comparative effects of ketanserin, a novel serotonergic receptor antagonist, on 5HT-induced shape change and 5HT uptake in rat and human platelets. Biochem. Pharmacol. 1982; 31: 3000
   PubMedGoogle Scholar
• Pletscher A. Metabolism, transfer and storage of 5-hydroxy-tryptamine in blood platelets. Br. J. Pharmacol. 1968; 32: 1
   PubMed Web of Science ®Google Scholar
• Aldinio C., Cerletti C., Manara L., Recchia M., Carlevaro G., De Molfetta V. Human platelet monoamine oxidase activity in glaucoma. Invest. Ophthalmol. Visual. Sci. 1979; 18: 320
   PubMedGoogle Scholar
• Chiabrando C., Noseda A., Castagnoli M.N., Salmona M., Fanelli R. Characterization of arachidonic acid metabolic profile in animal tissues by high-resolution gas chromatography-mass spectrometry. Biochim. Biophys. Acta. 1984; 794: 292
   PubMedGoogle Scholar
• Pace-Asciak C.R., Rangaraj G. Distribution of prostaglandin biosynthetic pathways in several rat tissues. Formation of 6-ketoprostaglandin F1. Biochim. Biophys. Acta. 1977; 486: 579
   PubMed Web of Science ®Google Scholar
• Ally A.I., Boucher R., Knowels M.R., Eling T.E. Metabolism of prostaglandin endoperoxide by microsomes from human lung parenchyma and comparison with metabolites produced by pig, bovine, rat, mouse and guinea pig. Prostaglandins 1982; 24: 575
   PubMedGoogle Scholar
• Sun F.F., Chapman J.P., McGuire J.C. Metabolism of prostaglandin endoperoxide in animal tissues. Prostaglandins 1977; 14: 1055
   PubMedGoogle Scholar
• Uotila P. Arachidonate metabolism is changed by dipyridamole in guinea pig isolated lungs. Acta Pharmacol. Toxicol. 1982; 50: 374
   PubMedGoogle Scholar
• Nowak J., Bohman S.O., Alster P., Berlin T., Cronestrand R., Sonnenfeld T. Biosynthesis of prostaglandins in microsomes of human skeletal muscle and kidney. Prostaglandins Leukotrienes Med. 1983; 11: 269
   PubMedGoogle Scholar
• Bristow M.R., Ginsburg R., Minobe W., Cubicciotti R.S., Sageman W.S., Lurie K., Billingham M.E., Harrison D.C., Stinson E.B. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N. Engl. J. Med. 1982; 307: 205
   PubMed Web of Science ®Google Scholar
• Weiss B., Greenberg L., Cantor E. Age-related alterations in the development of adrenergic denervation supersensitivity. Fed. Proc. 1979; 38: 1915
   PubMedGoogle Scholar
• Maggi A., Schmidt M.J., Ghetti B., Enna S.J. Effect of aging on neurotransmitter receptor binding in rat and human brain. Life Sci. 1979; 24: 367
   PubMed Web of Science ®Google Scholar
• Pantarotto C., Baggott J., Guaitani A., Donelli M.G., Garattini E. Secondary metabolism and covalent binding to cellular macromolecules. Quo Vadis? Short-term Tests for Carcinogenesis, S. Garattini, G. Mazue, R. Roncucci, G.M. Williams. Elsevier, Amsterdam 1983; 166
   Google Scholar
• De Blasi A., Cotecchia S., Lipartiti M., unpublished results
   Google Scholar